Neurofeedback for Tourette Syndrome

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT01702077
Collaborator
National Institute of Mental Health (NIMH) (NIH)
21
1
2
62
0.3

Study Details

Study Description

Brief Summary

The aim of this study is to train patients with tic disorders to control activity in a region of their brain that has been associated with the urge to tic. Patients will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. In separate sessions, patients will be given sham feedback based on the brain patterns of a prior subject rather than their own brain patterns. Our primary hypothesis is that the biofeedback training will reduce their tic symptoms more than the sham feedback.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Neurofeedback
  • Procedure: Sham feedback
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
21 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Neurofeedback of Activity in the Supplementary Motor Area for Tourette Syndrome
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
Dec 1, 2017
Actual Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neurofeedback first

Neurofeedback then sham feedback

Procedure: Neurofeedback
Other Names:
  • biofeedback
  • real-time fMRI biofeedback
  • Procedure: Sham feedback

    Experimental: Sham first

    Sham feedback then neurofeedback

    Procedure: Neurofeedback
    Other Names:
  • biofeedback
  • real-time fMRI biofeedback
  • Procedure: Sham feedback

    Outcome Measures

    Primary Outcome Measures

    1. Tic severity [Tic severity assessed approximately half a week PRIOR TO beginning biofeedback/sham feedback.]

      A modified version of the Yale Global Tic Severity Scale (YGTSS) will be used, that queries subjects regarding symptoms over the last 3 days (rather than the 2 week period used in the standard scale). Total YGTSS score on this modified scale will be used as the measure of tic severity.

    2. Tic severity [Tic severity assessed approximately half a week AFTER completing biofeedback/sham feedback.]

      A modified version of the Yale Global Tic Severity Scale (YGTSS) will be used, that queries subjects regarding symptoms over the last 3 days (rather than the 2 week period used in the standard scale). Total YGTSS score on this modified scale will be used as the measure of tic severity.

    Secondary Outcome Measures

    1. Control over target brain area [Assessed approximately half a week BEFORE biofeedback/sham biofeedback.]

      Control task scans will be conducted in which subjects are cued to alternately increase and decrease activity in their target area without receiving any feedback. The percent signal change in the BOLD signal in the target area during increase relative to decrease blocks will be used as the measure of control over the brain area.

    2. Control over target brain area [Assessed approximately half a week AFTER biofeedback/sham biofeedback.]

      Control task scans will be conducted in which subjects are cued to alternately increase and decrease activity in their target area without receiving any feedback. The percent signal change in the BOLD signal in the target area during increase relative to decrease blocks will be used as the measure of control over the brain area.

    Other Outcome Measures

    1. Functional connectivity patterns in the brain [Assessed approximately half a week BEFORE biofeedback/sham biofeedback.]

      Functional connectivity will be assessed based on temporal correlations in resting state functional imaging data.

    2. Functional connectivity patterns in the brain [Assessed approximately half a week AFTER biofeedback/sham biofeedback.]

      Functional connectivity will be assessed based on temporal correlations in resting state functional imaging data.

    3. Clinical improvement [Clinical improvement will be assessed approximately half a week AFTER biofeedback/sham feedback]

      The Clinical Global Impression - Improvement scale will be used to assess improvement over the course of the biofeedback/sham feedback

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    11 Years to 19 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of Tourette Syndrome or Chronic Tic Disorder

    • currently active tics

    • aged 11-19

    • ability to execute most common tics without moving head while lying on back

    Exclusion Criteria:
    • Blindness (because feedback is provided visually)

    • Lifetime diagnosis of pervasive developmental disorder, bipolar disorder, or psychotic disorder.

    • Presence of any serious psychiatric or psychosocial condition requiring initiation of new treatment or change in current treatment.

    • Neurological conditions affecting central nervous system, with the exception that predisposition to migraine will not be grounds for exclusion

    • Change in medication in the month prior to beginning the study

    • Unwillingness to keep medication stable over the course of the intervention

    • Full braces (but some retainers are OK)

    • Claustrophobia of a degree that they cannot comfortably be scanned

    • If common tics involve dramatic changes in breathing that could alter blood oxygenation measurements

    • Inability to keep head still while executing most common tics

    • Inability to keep head still in mock scanner

    • Inability or unwillingness to understand or follow the instructions

    • Pregnancy or possible pregnancy

    • Subjects may also be excluded after the first magnetic resonance scan if we are unable to localize a region of their supplementary motor area involved in tics - leaving us without a target area for biofeedback.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yale University School of Medicine New Haven Connecticut United States 06520

    Sponsors and Collaborators

    • Yale University
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Michelle Hampson, Ph.D., Yale University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yale University
    ClinicalTrials.gov Identifier:
    NCT01702077
    Other Study ID Numbers:
    • 0206017435
    • R01MH095789
    First Posted:
    Oct 5, 2012
    Last Update Posted:
    Aug 27, 2018
    Last Verified:
    Aug 1, 2018
    Keywords provided by Yale University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 27, 2018